ANVISA DocumentANVISA RDC 751/2022 Q&A — edition 2
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
Perguntas & Respostas — RDC nº 751, de 15 de setembro de 2022, 2ª edição is published by Agência Nacional de Vigilância Sanitária. This document is identified by its title; no separate official document code is recorded.
- Instrument
- Document
- Full name
- ANVISA RDC 751/2022 Q&A — edition 2
- Category
- Registration
- Source publication
- Portuguese
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Perguntas & Respostas — RDC nº 751, de 15 de setembro de 2022, 2ª edição
Complete 30-page official ANVISA medical-device Q&A, cover expressly second edition, Brasília 2 March 2023. Its final edition-history table identifies the correction to question 2. All questions, answers, original page layout, references, edition history and institutional credits are retained. The introduction expressly calls the guide non-regulatory and non-binding; its wording is not certified current 2026 law. Question 21 refers older product stock to RDC 751 Arts. 25–26 and does not itself state a 120-day period. Source-only preservation with no fact, fee, binding or question-status promotion.
This document is identified by its title; no separate official document code is recorded. Always confirm the current consolidated text and transition provisions with the official source before filing.